- University of Jordan School of Medicine, Amman, Jordan
Internship / Residency
- Internal Medicine - University of Texas Medical Branch, Galveston, TX
- Internal Medicine - King Hussein Cancer Center, Amman, Jordan
- General Practice - Zarqa Governmental Hospital, Zarqa, Jordan
- Medical Oncology & Internal Medicine – American Board of Internal Medicine
- Oncology - University of Texas Medical Branch, Galveston, TX
Issam Alawin, MD, joined Cancer Treatment Centers of America® (CTCA) in Tulsa, Oklahoma, in May 2018. An experienced medical oncologist who is board certified in internal medicine and medical oncology by the American Board of Internal Medicine, Dr. Alawin came to CTCA® to be part of a multidisciplinary team that provides conventional treatments to fight cancer and supportive therapies to manage cancer-related side effects, all under one roof. He works closely with each of his patients to deliver a thorough evaluation, individualized diagnosis and customized treatment plan. Dr. Alawin is also passionate about using today’s advances in cancer care, including genetic testing, targeted therapies and clinical trials.
“I believe we are living in the golden age of medical oncology,” says Dr. Alawin. “There have been so many changes and advancements in how we treat cancer. Since 2000, precision medicine has evolved, and hundreds of new targeted therapies have been released, helping us better target mutations. The field continues to develop, and patients will benefit from these advances in cancer treatment with better outcomes and fewer side effects.”
Dr. Alawin earned a medical degree from the University of Jordan School of Medicine in Amman, Jordan. He completed an internship in general practice from Zarqa Governmental Hospital in Zarqa, Jordan. Dr. Alawin completed a residency in internal medicine at King Hussein Cancer Center in Amman, Jordan. He then moved to the United States to further his training at the University of Texas Medical Branch in Galveston, Texas, by completing a residency in internal medicine and a fellowship in oncology.
Prior to joining CTCA, Dr. Alawin served as an oncologist in both outpatient and inpatient settings, and he has been a sub-investigator in numerous clinical trials. Dr. Alawin also teaches medical students and is a member of the American Society of Clinical Oncology.
Outside of CTCA, Dr. Alawin enjoys spending time with his wife and two young daughters. Together, they enjoy watching movies, going to the park and traveling.
Patient ratings and comments
Star ratings and comments are only available for medical, radiation and gynecologic oncologists. Gynecologic surgical offerings are not included at this time due to a different survey tool required to evaluate these services. CTCA uses a validated Press Ganey® survey, which captures patient experience feedback for the primary oncology services of chemotherapy and radiation therapy. Following industry best practice, star ratings and comments are only published for physicians with a minimum of 30 completed patient surveys.